NIPER Mohali presents a comprehensive academic ecosystem for 2026 through its nationally benchmarked postgraduate and doctoral programs, covering MPharm, MS (Pharm), MTech, MBA (Pharm), and PhD across 20+ high-demand pharmaceutical science domains. With a total of 291 PG seats offered through 11 specialized MPharm/MS (Pharm) disciplines—ranging from Medicinal Chemistry (46 seats) and Pharmaceutics (36 seats) to Pharmacology & Toxicology, Natural Products, Biotechnology, and Pharmacoinformatics—the institute ensures rigorous merit-based entry exclusively via NIPER JEE, supported by minimum eligibility of 60% in BPharm or related degrees. The MBA (Pharm) program adds 42 seats in Pharmaceutical Management for CAT/GMAT/NIPER JEE candidates, while the MTech in Pharmaceutical Technology provides 9 research-oriented seats in Formulations and Process Chemistry.
At the doctoral level, NIPER Mohali expands its research footprint with 73 PhD seats across 12 disciplines, including Pharmaceutical Analysis, Regulatory Toxicology, Pharmacy Practice, Traditional Medicine, and advanced biotech-driven domains. Each program integrates structured research, mandatory thesis components, 70% lab-based learning, and interdisciplinary exposure through industry collaborations and national-level projects. Supported by NAAC A++ accreditation, a 135-acre research-focused campus, modern laboratories, and specialized centers in drug design, toxicology, and computational pharmaceutics, NIPER Mohali continues to set India’s highest benchmark as an Institute of National Importance—making it the foremost destination for pharma research, innovation, and leadership development.
NIPER Mohali’s M.Pharm programs for 2026 are structured around 8 industry-aligned and research-driven specializations, each functioning as an independent advanced course. Every specialization offers a 2-year full-time curriculum, admitting students through NIPER JEE, with eligibility set at 60% in B.Pharm (55% for reserved categories). These courses emphasize laboratory research, regulatory skills, and pharmaceutical innovation, supported by a uniform fee of ₹2,29,560.
| M.Pharm Course / Specialization | Seats | Duration | Eligibility |
|---|---|---|---|
| M.Pharm in Medicinal Chemistry | 46 | 2 Years | 60% in B.Pharm |
| M.Pharm in Natural Products | 23 | 2 Years | 60% in B.Pharm |
| M.Pharm in Pharmaceutical Analysis | 23 | 2 Years | 60% in B.Pharm |
| M.Pharm in Pharmacology & Toxicology | 23 | 2 Years | 60% in B.Pharm |
| M.Pharm in Pharmaceutics | 36 | 2 Years | 60% in B.Pharm |
| M.Pharm in Regulatory Toxicology | 9 | 2 Years | 60% in B.Pharm |
| M.Pharm in Pharmacy Practice | 23 | 2 Years | 60% in B.Pharm |
| M.Pharm in Traditional Medicine | 17 | 2 Years | 60% in B.Pharm |
NIPER Mohali’s MS (Pharm) programs for 2026 focus on three advanced specializations designed to build strong research, biotechnology, and informatics expertise. Each course is a 2-year full-time, lab-driven program offered through NIPER JEE/GPAT, with eligibility starting at 60% in B.Pharm, B.Tech, or M.Sc depending on the specialization. The total fee for all streams is ₹2,29,560, making these programs highly competitive and research-oriented.
| MS (Pharm) Course / Specialization | Seats | Duration | Eligibility |
|---|---|---|---|
| MS (Pharm) in Biotechnology | 23 | 2 Years | 60% in B.Pharm / M.Sc |
| MS (Pharm) in Pharmacoinformatics | 23 | 2 Years | 60% in B.Pharm / B.Tech |
| MS (Pharm) in Pharmaceutical Technology (Biotech) | 18 | 2 Years | 60% in B.Pharm |
NIPER Mohali’s MTech programs for 2026 offer two highly specialized 2-year tracks designed for pharmaceutical technology aspirants seeking advanced formulation and process-chemistry expertise. Admission is based on GATE/NIPER JEE, with a minimum of 60% in B.Pharm or B.Tech. With a total program fee of ₹2,04,000, these courses emphasize research-driven learning and industry-aligned technical skills.
| MTech Specialization (Course) | Seats | Duration | Eligibility |
|---|---|---|---|
| MTech in Pharmaceutical Technology (Formulations) | 5 | 2 Years | 60% in B.Pharm / B.Tech |
| MTech in Pharmaceutical Technology (Process Chemistry) | 4 | 2 Years | 60% in B.Pharm / B.Tech |
NIPER Mohali’s MBA (Pharm) 2026 offers a focused 2-year specialization in Pharmaceutical Management, designed for graduates aiming for leadership, marketing, regulatory, and strategic roles in the pharma sector. Admissions are based on CAT/NIPER JEE, with a minimum of 60% in graduation. The program blends management principles with pharmaceutical industry insights at a total fee of ₹3,80,000.
| MBA (Pharm) Specialization (Course) | Seats | Duration | Eligibility |
|---|---|---|---|
| MBA in Pharmaceutical Management | 42 | 2 Years | 60% Graduation + CAT/NIPER JEE |
NIPER Mohali offers a full-time PhD Programme across 12 advanced pharmaceutical specializations, admitting 73 scholars through NIPER JEE followed by an interview. The program spans 3–5 years, requires 60% in a relevant Master’s degree, and includes an annual fee of ₹88,550.
| Course Name | Specialization | Seats | Duration | Eligibility |
|---|---|---|---|---|
| PhD | Biotechnology | 6 | 3–5 Years | 60% Master’s |
| PhD | Medicinal Chemistry | 6 | 3–5 Years | 60% Master’s |
| PhD | Natural Products | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharmaceutical Analysis | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharmacology & Toxicology | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharmaceutics | 6 | 3–5 Years | 60% Master’s |
| PhD | Regulatory Toxicology | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharmacy Practice | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharmacoinformatics | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharma Tech (Formulations) | 6 | 3–5 Years | 60% Master’s |
| PhD | Pharma Tech (Process Chemistry) | 6 | 3–5 Years | 60% Master’s |
| PhD | Traditional Medicine | 7 | 3–5 Years | 60% Master’s |
Overall: The university provides a balanced environment for both academic and personal growth. The faculty members are well-qualified, approachable, and supportive, ensuring that students gain a strong understanding of their subjects.
Faculty: The faculty at this University plays a vital role in shaping the overall academic experience of students. Most of the professors and lecturers are highly qualified, with strong academic backgrounds
Overall: Has quickly emerged as a promising institution in higher education known for its modern infrastructure and industry aligned courses the university offers a diverse range of programmes
Faculty: Faculty members are generally qualified and supportive with many having industry and research experience hands on learning and skill development often organising workshops
NIPER Mohali’s PhD programs in 2026 span 3–5 years depending on research scope and specialization. The annual project/research fee is ₹88,550. Admissions require a Master’s degree with at least 60% marks and selection through NIPER JEE plus an interview. The program covers 12 disciplines including Biotechnology, Medicinal Chemistry, and Pharmaceutical Technology, integrating lab-based research, thesis work, and industry collaboration. The structure ensures deep specialization and scholarly output. Students are trained in experimental techniques, computational analysis, and translational research, preparing them for academic, industrial, and regulatory roles in the pharmaceutical and biotechnology sectors.
The MBA (Pharm) program at NIPER Mohali 2026 offers 42 seats in Pharmaceutical Management. Admission requires graduation with at least 60% marks and scores from CAT or NIPER JEE. This two-year full-time program blends management principles with pharmaceutical industry knowledge, preparing graduates for leadership, strategy, and regulatory roles. The total fee is ₹3,80,000. Students receive training in marketing, supply chain management, and pharma-specific business operations, combining classroom learning with industry exposure. This ensures that graduates are ready to take up mid-to-senior level managerial roles in pharmaceutical companies, regulatory agencies, and healthcare organizations.
MTech applicants at NIPER Mohali 2026 must hold a B.Pharm or B.Tech degree with a minimum of 60% marks (55% for reserved categories). Admission requires valid GATE or NIPER JEE scores. Programs are two years full-time, with specialization in Pharmaceutical Technology (Formulations or Process Chemistry). These courses emphasize advanced research, industrial applications, and lab-oriented learning. The total fee is ₹2,04,000. Candidates gain skills in formulation science, process chemistry, and pharmaceutical technology innovations. Eligibility criteria ensure that students entering these research-intensive programs have sufficient academic and technical preparation for successful completion and industry readiness.
NIPER Mohali offers a wide range of postgraduate programs in 2026, including MPharm, MS (Pharm), MTech, and MBA (Pharm). MPharm programs span eight research-driven specializations like Medicinal Chemistry, Pharmaceutics, and Pharmacology & Toxicology, totaling 291 seats. MS (Pharm) includes Biotechnology, Pharmacoinformatics, and Pharmaceutical Technology (Biotech). MTech focuses on Pharmaceutical Technology in Formulations and Process Chemistry with nine research-oriented seats. The MBA (Pharm) provides 42 seats in Pharmaceutical Management. Admissions are primarily through NIPER JEE, with CAT or GPAT scores applicable for certain programs. Each course emphasizes lab-based learning, industry exposure, and structured research.
NIPER Mohali’s MPharm program offers eight specialized disciplines in 2026, each designed for intensive research and industry relevance. These include Medicinal Chemistry (46 seats), Natural Products (23), Pharmaceutical Analysis (23), Pharmacology & Toxicology (23), Pharmaceutics (36), Regulatory Toxicology (9), Pharmacy Practice (23), and Traditional Medicine (17). Each specialization runs a two-year full-time curriculum with eligibility of 60% in B.Pharm (55% for reserved categories). Courses emphasize laboratory research, regulatory insights, and pharmaceutical innovation. Admissions are conducted via NIPER JEE, ensuring merit-based selection. The uniform fee for all MPharm programs is ₹2,29,560.
NIPER Mohali’s MS (Pharm) programs in 2026 are designed for research-oriented students in Biotechnology, Pharmacoinformatics, and Pharmaceutical Technology (Biotech). Each course spans two years full-time, with lab-intensive and project-based training. Eligibility requires a minimum of 60% in B.Pharm, B.Tech, or M.Sc, depending on the specialization. Admissions occur through NIPER JEE or GPAT. Total seats include 23 each for Biotechnology and Pharmacoinformatics and 18 for Pharmaceutical Technology (Biotech). The fee for all MS streams is ₹2,29,560. The programs focus on integrating theoretical knowledge with hands-on research skills, preparing graduates for careers in pharmaceutical R&D, biotechnology, and computational informatics.
In 2026, NIPER Mohali offers two MTech specializations, Pharmaceutical Technology (Formulations) with 5 seats and Pharmaceutical Technology (Process Chemistry) with 4 seats. Both are two-year full-time programs emphasizing advanced research, industry-aligned technical skills, and lab-based learning. Admissions are based on GATE or NIPER JEE scores, with minimum 60% in B.Pharm or B.Tech required. The total fee for both programs is ₹2,04,000. These courses aim to equip students with expertise in formulation science, process chemistry, and advanced pharmaceutical technologies, aligning academic learning with industrial applications in drug design, development, and manufacturing.
NIPER Mohali’s MBA (Pharm) 2026 offers a two-year specialization in Pharmaceutical Management for 42 students. The program targets graduates with 60% marks and accepts CAT/NIPER JEE scores for admission. The curriculum integrates business management principles with pharmaceutical industry insights, preparing students for leadership roles in marketing, strategy, regulatory affairs, and supply chain management. Total fees are ₹3,80,000. The course emphasizes a balance of theory and practical industry exposure, including case studies, internships, and project work, ensuring graduates acquire both managerial and sector-specific expertise critical for high-demand positions in India’s pharmaceutical and biotech industries.
NIPER Mohali offers 73 PhD seats across 12 disciplines for 2026. The programs span 3–5 years and admit candidates through NIPER JEE followed by an interview. Each discipline requires a minimum of 60% in a relevant Master’s degree. Specializations include Biotechnology, Medicinal Chemistry, Natural Products, Pharmaceutical Analysis, Pharmacology & Toxicology, Pharmaceutics, Regulatory Toxicology, Pharmacy Practice, Pharmacoinformatics, Pharmaceutical Technology (Formulations & Process Chemistry), and Traditional Medicine. The annual project/research fee is ₹88,550. PhD programs integrate structured research, thesis work, and industry collaboration, providing advanced academic and practical training in specialized pharmaceutical domains.
Among MPharm programs at NIPER Mohali 2026, Medicinal Chemistry has the highest seat allocation with 46 seats. This specialization emphasizes laboratory-based research, regulatory skills, and pharmaceutical innovation. It is followed by Pharmaceutics with 36 seats. All MPharm programs have a two-year duration and admit students via NIPER JEE with minimum 60% marks in B.Pharm. Each specialization provides exposure to advanced lab techniques, drug design, and formulation studies, ensuring graduates are well-prepared for pharmaceutical R&D roles in both academic and industrial sectors. The fee is uniform at ₹2,29,560 per program.
Mohali (Punjab)
Mohali (Punjab)
Mohali (Punjab)